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Background: Patients with repaired tetralogy of Fallot (rtoF) are at risk of arrhythmia, right ventricular (RV) dilatation and dysfunction, and sudden 
death during long term follow-up. Frequently, pulmonary valve replacement (PVR) is indicated. To date, risk stratification focuses on QRS duration 
and right and left ventricular dysfunction. Recent studies reveal an increasingly important role for atrial size and function in outcomes prediction in 
non-congenital cardiomyopathies. We hypothesised that atrial dilatation would also relate to outcomes in rtoF.
Methods: Retrospective analysis for atrial size was performed in 154 rtoF patients attending cardiovascular magnetic resonance (CMR) imaging 
from 2002 to 2008. Atrial area was measured on cine CMR 4-chamber view at end-systole. Clinical data were collected. Echocardiography 
contemporaneous to CMR was evaluated for restrictive RV physiology. The primary composite endpoint was new onset of clinically documented 
arrhythmia and/or death. The secondary combined endpoint was arrhythmia, death and/or PVR during follow-up.
Results: Median [IQR] age at CMR was 30.8 [21.4-40.2] years. Median follow-up was 6.0 [4.6-6.9] years. During follow-up there were 3 deaths, 22 
new onset arrhythmias (12 atrial tachycardia of which 1 atrial fibrillation, 10 ventricular) and 50 PVRs. RA area indexed to body surface area (RAAi) 
strongly correlated with arrhythmia or death (ROC analysis, AUC 0.68 [0.60-0.75], p=0.0035), with a cut-off value of 13.6 cm2/m2. The predictive 
value of RAAi was greater in rtoF with restrictive RV physiology (AUC 0.83 [0.62-0.95], p=0.0001). RV end-diastolic volume index (RVEDVi) was less 
significantly related to arrhythmia or death (AUC 0.61[0.53-0.69], p=0.053). As expected, RVEDVi was correlated to the secondary combined end-
point including PVR more strongly than RAAi (AUC 0.71[0.63-0.78], p<0.0001 and AUC 0.62[0.54-0.7], p<0.001, respectively). Left atrial size did 
not relate to outcomes.
Conclusion: RAAi is a strong predictor of arrhythmia and death in rtoF, even more so in the subset of rtoF with restrictive RV physiology. Right atrial 
area measurement is feasible and widely available to inform clinical decision-making.
